Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Non-Small-Cell Lung | 29 | 2023 | 5221 | 2.600 |
Why?
|
Lung Neoplasms | 43 | 2023 | 13102 | 2.540 |
Why?
|
Acrylamides | 14 | 2021 | 255 | 2.410 |
Why?
|
Aniline Compounds | 15 | 2023 | 986 | 1.700 |
Why?
|
Protein Kinase Inhibitors | 25 | 2023 | 5535 | 1.680 |
Why?
|
Drug Resistance, Neoplasm | 18 | 2023 | 5172 | 1.180 |
Why?
|
Mutation | 33 | 2023 | 29786 | 0.790 |
Why?
|
Exons | 7 | 2023 | 2437 | 0.760 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2018 | 434 | 0.660 |
Why?
|
Resorcinols | 1 | 2018 | 38 | 0.660 |
Why?
|
Antineoplastic Agents | 13 | 2021 | 13695 | 0.630 |
Why?
|
Mutagenesis, Insertional | 3 | 2021 | 655 | 0.610 |
Why?
|
Isoxazoles | 1 | 2018 | 216 | 0.590 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2018 | 220 | 0.580 |
Why?
|
Molecular Targeted Therapy | 8 | 2023 | 2727 | 0.530 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2018 | 388 | 0.490 |
Why?
|
Biopsy, Fine-Needle | 1 | 2019 | 1094 | 0.470 |
Why?
|
Pyrimidines | 5 | 2021 | 2942 | 0.390 |
Why?
|
Piperazines | 3 | 2017 | 2488 | 0.350 |
Why?
|
Picornaviridae Infections | 1 | 2009 | 88 | 0.310 |
Why?
|
Rhinovirus | 1 | 2009 | 187 | 0.300 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4034 | 0.290 |
Why?
|
Adenocarcinoma | 4 | 2018 | 6364 | 0.270 |
Why?
|
Respiratory Sounds | 1 | 2009 | 696 | 0.250 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2021 | 11524 | 0.230 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2019 | 713 | 0.230 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3086 | 0.220 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 2021 | 61 | 0.200 |
Why?
|
Cytidine Deaminase | 1 | 2023 | 252 | 0.200 |
Why?
|
Respiratory Tract Infections | 1 | 2009 | 961 | 0.200 |
Why?
|
Humans | 55 | 2023 | 744343 | 0.190 |
Why?
|
Hepatocyte Growth Factor | 1 | 2021 | 270 | 0.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2021 | 8428 | 0.170 |
Why?
|
Disease Progression | 6 | 2021 | 13284 | 0.160 |
Why?
|
Genetic Heterogeneity | 3 | 2020 | 733 | 0.160 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 250 | 0.160 |
Why?
|
Cell Line, Tumor | 7 | 2019 | 16689 | 0.150 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2019 | 142 | 0.150 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2022 | 1157 | 0.150 |
Why?
|
Quinazolinones | 1 | 2018 | 221 | 0.140 |
Why?
|
Eligibility Determination | 1 | 2020 | 403 | 0.140 |
Why?
|
Diarrhea | 1 | 2023 | 1348 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 648 | 0.130 |
Why?
|
Middle Aged | 20 | 2023 | 213383 | 0.130 |
Why?
|
Neoplasm Metastasis | 3 | 2021 | 4851 | 0.130 |
Why?
|
Carcinoma, Small Cell | 1 | 2017 | 420 | 0.130 |
Why?
|
Female | 26 | 2023 | 380194 | 0.120 |
Why?
|
Gene Amplification | 2 | 2016 | 1063 | 0.120 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 7913 | 0.120 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2019 | 1581 | 0.120 |
Why?
|
Aged, 80 and over | 11 | 2021 | 57776 | 0.120 |
Why?
|
Retreatment | 1 | 2015 | 610 | 0.120 |
Why?
|
Hemoglobins | 1 | 2019 | 1534 | 0.110 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 1364 | 0.110 |
Why?
|
Myenteric Plexus | 1 | 2012 | 39 | 0.110 |
Why?
|
Indoles | 1 | 2021 | 1839 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2017 | 1660 | 0.100 |
Why?
|
Aged | 16 | 2021 | 163280 | 0.100 |
Why?
|
Male | 19 | 2023 | 350118 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1692 | 0.100 |
Why?
|
Prognosis | 4 | 2020 | 29063 | 0.090 |
Why?
|
Translocation, Genetic | 1 | 2016 | 1420 | 0.090 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2019 | 3557 | 0.090 |
Why?
|
Cohort Studies | 5 | 2021 | 40561 | 0.090 |
Why?
|
DNA, Neoplasm | 1 | 2015 | 1758 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2019 | 2043 | 0.090 |
Why?
|
Quinazolines | 1 | 2016 | 1356 | 0.090 |
Why?
|
Medical Oncology | 1 | 2020 | 2265 | 0.080 |
Why?
|
Maximum Tolerated Dose | 2 | 2021 | 892 | 0.080 |
Why?
|
Mice, Nude | 3 | 2019 | 3689 | 0.080 |
Why?
|
Survival Rate | 2 | 2021 | 12788 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4215 | 0.080 |
Why?
|
Cell Proliferation | 3 | 2020 | 10481 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2021 | 63114 | 0.070 |
Why?
|
Molecular Epidemiology | 1 | 2009 | 468 | 0.070 |
Why?
|
Base Pair Mismatch | 2 | 2003 | 97 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4751 | 0.070 |
Why?
|
Adult | 14 | 2021 | 214055 | 0.070 |
Why?
|
Gastrointestinal Tract | 1 | 2012 | 814 | 0.070 |
Why?
|
Radiosurgery | 1 | 2015 | 1329 | 0.070 |
Why?
|
Sulfonamides | 3 | 2020 | 1938 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2021 | 578 | 0.060 |
Why?
|
Terminal Care | 1 | 2016 | 1694 | 0.060 |
Why?
|
Benzamides | 2 | 2021 | 1379 | 0.060 |
Why?
|
Alleles | 1 | 2015 | 6933 | 0.060 |
Why?
|
Microsatellite Repeats | 2 | 2003 | 802 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2016 | 13033 | 0.060 |
Why?
|
Models, Biological | 1 | 2019 | 9583 | 0.050 |
Why?
|
Cell Survival | 3 | 2019 | 5882 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9239 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2023 | 77449 | 0.050 |
Why?
|
Apoptosis | 4 | 2019 | 9727 | 0.050 |
Why?
|
Phylogeny | 1 | 2009 | 2803 | 0.050 |
Why?
|
Sequence Analysis, RNA | 1 | 2009 | 2012 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39050 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2019 | 6314 | 0.050 |
Why?
|
Surge Capacity | 1 | 2020 | 42 | 0.050 |
Why?
|
Intestinal Neoplasms | 1 | 2003 | 319 | 0.050 |
Why?
|
Platinum | 1 | 2021 | 233 | 0.050 |
Why?
|
Radiobiology | 1 | 2020 | 85 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4462 | 0.040 |
Why?
|
RNA, Small Interfering | 2 | 2019 | 3505 | 0.040 |
Why?
|
Genomic Instability | 1 | 2023 | 695 | 0.040 |
Why?
|
Diphenylamine | 1 | 2018 | 50 | 0.040 |
Why?
|
Triazines | 1 | 2021 | 315 | 0.040 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2003 | 604 | 0.040 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2023 | 594 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2023 | 1526 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.040 |
Why?
|
Lung | 1 | 2017 | 9856 | 0.040 |
Why?
|
Cell Growth Processes | 1 | 2019 | 399 | 0.040 |
Why?
|
Keratin-8 | 1 | 2017 | 11 | 0.040 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2018 | 97 | 0.040 |
Why?
|
Cell Cycle | 2 | 2017 | 2967 | 0.040 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2019 | 237 | 0.040 |
Why?
|
Keratin-18 | 1 | 2017 | 39 | 0.040 |
Why?
|
Biopsy | 2 | 2021 | 6756 | 0.040 |
Why?
|
Prospective Studies | 3 | 2021 | 53288 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2019 | 371 | 0.040 |
Why?
|
Lactams | 1 | 2017 | 156 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2018 | 8863 | 0.040 |
Why?
|
Pyrazoles | 2 | 2017 | 1972 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2020 | 2327 | 0.040 |
Why?
|
Lactams, Macrocyclic | 1 | 2017 | 320 | 0.030 |
Why?
|
North America | 1 | 2018 | 1249 | 0.030 |
Why?
|
Pyridines | 2 | 2017 | 2825 | 0.030 |
Why?
|
Pyridones | 1 | 2019 | 712 | 0.030 |
Why?
|
Imidazoles | 1 | 2021 | 1206 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 890 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10943 | 0.030 |
Why?
|
Time Factors | 3 | 2021 | 40075 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 542 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2021 | 2007 | 0.030 |
Why?
|
Gene Expression | 2 | 2017 | 7799 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2505 | 0.030 |
Why?
|
Physician's Role | 1 | 2020 | 943 | 0.030 |
Why?
|
Codon | 1 | 2015 | 611 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2716 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1375 | 0.030 |
Why?
|
Tumor Burden | 1 | 2018 | 1915 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2021 | 3479 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4217 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 944 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 2077 | 0.020 |
Why?
|
Mice | 4 | 2019 | 81183 | 0.020 |
Why?
|
Gene Dosage | 1 | 2016 | 1252 | 0.020 |
Why?
|
Animals | 6 | 2019 | 168757 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2019 | 2382 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5078 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1038 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 1791 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6538 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2019 | 2107 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3586 | 0.020 |
Why?
|
DNA Damage | 1 | 2019 | 2432 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1861 | 0.020 |
Why?
|
Mushroom Poisoning | 1 | 1968 | 6 | 0.020 |
Why?
|
Hospitalization | 1 | 2009 | 10262 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2531 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18029 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2012 | 11366 | 0.020 |
Why?
|
Neoplasms | 1 | 2017 | 21683 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 2948 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2020 | 3589 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5179 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4186 | 0.020 |
Why?
|
Infant | 1 | 2009 | 35136 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2015 | 1373 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11031 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4445 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5867 | 0.020 |
Why?
|
Signal Transduction | 2 | 2021 | 23403 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6895 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 5987 | 0.020 |
Why?
|
Young Adult | 2 | 2021 | 56430 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2018 | 14557 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2003 | 6773 | 0.010 |
Why?
|
Adolescent | 3 | 2021 | 85781 | 0.010 |
Why?
|
MutS Homolog 2 Protein | 1 | 2003 | 200 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6234 | 0.010 |
Why?
|
Swine | 1 | 2012 | 5917 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12951 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16365 | 0.010 |
Why?
|
Neoplasm Proteins | 2 | 2003 | 3703 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17446 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2003 | 2025 | 0.010 |
Why?
|
Age of Onset | 1 | 2003 | 3271 | 0.010 |
Why?
|
Rats | 1 | 2012 | 24260 | 0.010 |
Why?
|
Quality of Life | 1 | 2016 | 12804 | 0.010 |
Why?
|
DNA Repair | 1 | 2003 | 2046 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2016 | 20129 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2003 | 2916 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2003 | 4554 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2003 | 5021 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2003 | 5853 | 0.000 |
Why?
|
Age Factors | 1 | 2003 | 18370 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9648 | 0.000 |
Why?
|